Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03669718
What this trial is testing

Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

Who this might be right for
Squamous Cell Carcinoma of the OropharynxHPV16 Positive
ISA Pharmaceuticals 194
Testing effectiveness (Phase 2)Looking for participantsNCT06677190
What this trial is testing

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

Who this might be right for
Ovarian CancerOvarian CarcinomaEndometrial Cancer+5 more
Dana-Farber Cancer Institute 32
Testing effectiveness (Phase 2)Study completedNCT00109590
What this trial is testing

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 175
Not applicableStudy completedNCT00029913
What this trial is testing

Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials

Who this might be right for
HIV Infections
HIV Vaccine Trials Network 54
Not applicableStudy completedNCT02581020
What this trial is testing

The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects

Who this might be right for
Hepatitis C Virus
AbbVie 344
Testing effectiveness (Phase 2)Looking for participantsNCT06259123
What this trial is testing

Neoadjuvant PSMA-RLT in Oligometastatic PCa

Who this might be right for
Prostate Cancer
Medical University of Vienna 10
Early research (Phase 1)Study completedNCT00004579
What this trial is testing

See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection

Who this might be right for
HIV InfectionsHIV Seronegativity
Walter Reed Army Institute of Research (WRAIR)
Testing effectiveness (Phase 2)Study completedNCT03839446
What this trial is testing

Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy

Who this might be right for
Acute Myeloid Leukemia
Robert Redner, MD 16
Testing effectiveness (Phase 2)Study completedNCT03265288
What this trial is testing

Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults

Who this might be right for
Cystic Fibrosis
Laurent Pharmaceuticals Inc. 166
Testing effectiveness (Phase 2)Study completedNCT00289627
What this trial is testing

A Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 155
Testing effectiveness (Phase 2)Study completedNCT01236638
What this trial is testing

Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)

Who this might be right for
Primary MyelofibrosisPost-Polycythemia Vera MyelofibrosisPost-Essential Thrombocythemia Myelofibrosis
Sierra Oncology LLC - a GSK company 120
Testing effectiveness (Phase 2)Study completedNCT02031458
What this trial is testing

Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 667
Not applicableStudy completedNCT04407026
What this trial is testing

Oral and Systemic Levels of TFF-1 and TTF-3 in Periodontal Diseases

Who this might be right for
Periodontal Diseases
Aydin Adnan Menderes University 100
Testing effectiveness (Phase 2)Study completedNCT01396226
What this trial is testing

A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients

Who this might be right for
Arrhythmia
AstraZeneca 20
Not applicableStudy completedNCT06277115
What this trial is testing

Acute and Long-term Effects of CPAP in OSA

Who this might be right for
Obstructive Sleep Apnea of Adult
University of Zurich 36
Testing effectiveness (Phase 2)Study completedNCT00541008
What this trial is testing

Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer

Who this might be right for
Kidney Cancer
UNICANCER 92
Testing effectiveness (Phase 2)Study completedNCT01025076
What this trial is testing

Evaluation of the Safety and Effectiveness of Stomaphyx for Transoral Incisionless Reduction of the Enlarged Gastric Pouch and Stoma

Who this might be right for
Morbid Obesity
University of Alberta 14
Testing effectiveness (Phase 2)UnknownNCT03900676
What this trial is testing

Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris

Who this might be right for
Acne Vulgaris
Vyome Therapeutics Inc. 480
Testing effectiveness (Phase 2)UnknownNCT00531089
What this trial is testing

Rituximab in Patients With Relapsed or Refractory TTP-HUS

Who this might be right for
Thrombotic Thrombocytopenic PurpuraHemolytic Uremic Syndrome
Hamilton Health Sciences Corporation 60
Testing effectiveness (Phase 2)WithdrawnNCT03644589
What this trial is testing

Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeMetastatic Breast Cancer+3 more
University of Washington
Next Page